The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Members of the World Health Organization have adopted a landmark agreement on how to prepare for future pandemics following ...

Annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Donald Trump administration.

The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.